{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:33:27Z","timestamp":1773236007963,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T00:00:00Z","timestamp":1112054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1038\/sj.bjc.6602505","type":"journal-article","created":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T17:23:31Z","timestamp":1112117011000},"page":"1288-1292","source":"Crossref","is-referenced-by-count":50,"title":["Second primary malignancies in patients with male breast cancer"],"prefix":"10.1038","volume":"92","author":[{"given":"K","family":"Hemminki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Sc\u00e9lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Boffetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Mellemkjaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D H","family":"Brewster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Pukkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E V","family":"Kliewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K-S","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Pompe-Kirn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Martos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J G","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,29]]},"reference":[{"key":"BF6602505_CR1","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/jnci\/94.17.1330","volume":"94","author":"A Auvinen","year":"2002","unstructured":"Auvinen A, Curstis R, Ron E (2002) Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94: 1330\u20131332","journal-title":"J Natl Cancer Inst"},{"key":"BF6602505_CR2","first-page":"1361","volume":"17","author":"A Buzdar","year":"2003","unstructured":"Buzdar A (2003) Breast cancer in men. Oncology 17: 1361\u20131364","journal-title":"Oncology"},{"key":"BF6602505_CR3","first-page":"855","volume":"8","author":"Y Chen","year":"1999","unstructured":"Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8: 855\u2013861","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6602505_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1010639429207","volume":"66","author":"C Dong","year":"2001","unstructured":"Dong C, Hemminki K (2001) Second primary breast cancer in men. Breast Cancer Res Treat 66: 171\u2013172","journal-title":"Breast Cancer Res Treat"},{"key":"BF6602505_CR5","first-page":"663","volume":"24","author":"R Gennari","year":"2004","unstructured":"Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M, Galimberti V, Luini A, Orecchia R, Viale G, Goldhrisch A, Veronesi U (2004) Male breast cancer: a special therapeutic problem. Anything new? [review]. Int J Oncol 24: 663\u2013670","journal-title":"Int J Oncol"},{"key":"BF6602505_CR6","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1093\/jnci\/94.24.1892","volume":"94","author":"K Hemminki","year":"2002","unstructured":"Hemminki K, Granstrom C (2002) Re: Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94: 1892","journal-title":"J Natl Cancer Inst"},{"key":"BF6602505_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0959-8049(02)00595-6","volume":"39","author":"K Hemminki","year":"2003","unstructured":"Hemminki K, Jiang Y, Steineck G (2003a) Skin cancer and non-Hodgkin's lymphoma as second malignancies: markers of impaired immune function? Eur J Cancer 39: 223\u2013229","journal-title":"Eur J Cancer"},{"key":"BF6602505_CR8","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO;2-R","volume":"92","author":"K Hemminki","year":"2001","unstructured":"Hemminki K, Li X (2001) Incidence trends and risk factors of carcinoid tumors. Cancer 92: 2204\u20132210","journal-title":"Cancer"},{"key":"BF6602505_CR9","first-page":"796","volume":"12","author":"K Hemminki","year":"2003","unstructured":"Hemminki K, Li X (2003) Level of education and the risk of cancer in Sweden. Cancer Epidemiol Biomarkers Prev 12: 796\u2013802","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6602505_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.11150","volume":"105","author":"K Hemminki","year":"2003","unstructured":"Hemminki K, Zhang H, Czene K (2003b) Socioeconomic factors in cancer in Sweden. Int J Cancer 105: 692\u2013700","journal-title":"Int J Cancer"},{"key":"BF6602505_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1023\/A:1008869003012","volume":"9","author":"AW Hsing","year":"1998","unstructured":"Hsing AW, McLaughlin JK, Cocco P, Co Chien HT, Fraumeni Jr JF (1998) Risk factors for male breast cancer (United States). Cancer Causes Control 9: 269\u2013275","journal-title":"Cancer Causes Control"},{"key":"BF6602505_CR12","first-page":"4293","volume":"17","author":"R Hultborn","year":"1997","unstructured":"Hultborn R, Hanson C, Kopf I, Verbiene I, Warnhammar E, Weimarck A (1997) Prevalence of Klienefelter's syndrome in male breast cancer patients. Anticancer Res 17: 4293\u20134297","journal-title":"Anticancer Res"},{"key":"BF6602505_CR13","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","volume":"22","author":"A Liede","year":"2004","unstructured":"Liede A, Karlan BY, Narod SA (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22: 735\u2013742","journal-title":"J Clin Oncol"},{"key":"BF6602505_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2457::AID-CNCR2>3.0.CO;2-I","volume":"86","author":"H Lynch","year":"1999","unstructured":"Lynch H, Watson P, Narod S (1999) The genetic epidemiology of male breast carcinoma. Cancer 86: 244\u2013246","journal-title":"Cancer"},{"key":"BF6602505_CR15","first-page":"64","volume-title":"Cancer Registration: Priciples and Methods","author":"C Muir","year":"1991","unstructured":"Muir C, Percy C (1991) Classification and coding of neoplasms. In Cancer Registration: Priciples and Methods Jensen O, Parkin D, MacLennan R, Muir C, Skeet R (eds) Vol. 95, pp 64\u201381. Lyon: IARC Science Publications"},{"key":"BF6602505_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1200\/JCO.2000.18.3.498","volume":"18","author":"A Swerdlow","year":"2000","unstructured":"Swerdlow A, Barber J, Hudson G, Cunningham D, Gupta R, Hancock B, Horwich A, Lister T, Linch D (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 18: 498\u2013509","journal-title":"J Clin Oncol"},{"key":"BF6602505_CR17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/1097-0215(20001215)88:6<998::AID-IJC25>3.0.CO;2-0","volume":"88","author":"P Vaittinen","year":"2000","unstructured":"Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88: 998\u20131002","journal-title":"Int J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602505.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602505","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602505.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:15:50Z","timestamp":1684412150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,29]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["BF6602505"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602505","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,29]]}}}